Form 4 Filing for BIOCRYST PHARMACEUTICALS INC - MILANO VINCENT

Vincent Milano, a director at BIOCRYST PHARMACEUTICALS INC, acquired 1159 shares of Common Stock on August 31, 2026. The acquisition was made in lieu of 50% of the quarterly cash Board Chair retainer, with a transaction price of $9.70 per share. Following this transaction, Milano owns 109,642 shares of Common Stock. The transaction code was 'A', indicating an acquisition, and the ownership is direct.